Khiron Life Sciences Corp. (KHRNF)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0650 - Volume
3,000 - Avg. Volume
37,706 - Market Cap (intraday)
778 - Beta (5Y Monthly) 2.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
khiron.ca--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: KHRNF
Performance Overview: KHRNF
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KHRNF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KHRNF
Valuation Measures
Market Cap
2.09M
Enterprise Value
2.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
0.11
Enterprise Value/Revenue
0.16
Enterprise Value/EBITDA
-0.09
Financial Highlights
Profitability and Income Statement
Profit Margin
-190.00%
Return on Assets (ttm)
-20.79%
Return on Equity (ttm)
-74.68%
Revenue (ttm)
16.14M
Net Income Avi to Common (ttm)
-30.66M
Diluted EPS (ttm)
-0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.94M
Total Debt/Equity (mrq)
9.46%
Levered Free Cash Flow (ttm)
-8.83M
Company Insights: KHRNF
KHRNF does not have Company Insights